In conclusion, our study provides significant insights into how BORC-Arl8b-mediated lysosomal trafficking increases invasiveness in IR-S cells, thereby providing a basis for the development of a novel strategy to improve cancer treatment. The gene discussed is ARL8B; the disease is cancer.